{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:15:22Z","timestamp":1787026522270,"version":"build-2736575974"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T00:00:00Z","timestamp":1588896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004690","name":"Minist\u00e8re de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004690","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00840","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T01:18:45Z","timestamp":1588900725000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Immune Defect in Adults With Down Syndrome: Insights Into a Complex Issue"],"prefix":"10.3389","volume":"11","author":[{"given":"Yannick","family":"Dieudonn\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Uring-Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Maxime","family":"Jeljeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Gies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Alembik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Korganow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Guffroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/S0140-6736(03)12987-X","article-title":"Down\u2019s syndrome.","volume":"361","author":"Roizen","year":"2003","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/eurpub\/ckl103","article-title":"The four ages of Down syndrome.","volume":"17","author":"Bittles","year":"2007","journal-title":"Eur J Public Health."},{"key":"B3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2249.2011.04335.x","article-title":"Infections and immunodeficiency in Down syndrome.","volume":"164","author":"Ram","year":"2011","journal-title":"Clin Exp Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.devcel.2018.07.008","article-title":"Trisomy 21 represses cilia formation and function.","volume":"46","author":"Galati","year":"2018","journal-title":"Dev Cell."},{"key":"B5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/pai.13133","article-title":"Clinical implications of immune-mediated diseases in children with Down syndrome.","volume":"31","author":"Verstegen","year":"2020","journal-title":"Pediatr Allergy Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1365-2249.2009.03890.x","article-title":"Intrinsic defect of the immune system in children with Down syndrome: a review.","volume":"156","author":"Kusters","year":"2009","journal-title":"Clin Exp Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.jaci.2014.07.015","article-title":"Defective B-cell memory in patients with Down syndrome.","volume":"134","author":"Verstegen","year":"2014","journal-title":"J Allergy Clin Immunol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/eji.201445049","article-title":"Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome.","volume":"45","author":"Carsetti","year":"2015","journal-title":"Eur J Immunol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00447","article-title":"Thymic epithelium abnormalities in DiGeorge and Down syndrome patients contribute to dysregulation in T cell development.","volume":"10","author":"Marcovecchio","year":"2019","journal-title":"Front Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.7326\/0003-4819-136-9-200205070-00008","article-title":"Serologic immunity to diphtheria and tetanus in the United States.","volume":"136","author":"McQuillan","year":"2002","journal-title":"Ann Intern Med."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01862","article-title":"Value of the overall pneumococcal polysaccharide response in the diagnosis of primary humoral immunodeficiencies.","volume":"8","author":"Lopez","year":"2017","journal-title":"Front Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1136\/annrheumdis-2017-212789","article-title":"Impaired long-term immune protection following pneumococcal 13-valent\/23-valent polysaccharide vaccine in systemic lupus erythematosus (SLE).","volume":"77","author":"Sacre","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.dib.2017.04.019","article-title":"Reference values for T, B and NK human lymphocyte subpopulations in adults.","volume":"12","author":"Apoil","year":"2017","journal-title":"Data Brief."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.jaci.2018.02.017","article-title":"Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood.","volume":"141","author":"Blanco","year":"2018","journal-title":"J Allergy Clin Immunol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03058","article-title":"The pattern of malignancies in Down syndrome and its potential context with the immune system.","volume":"9","author":"Satg\u00e9","year":"2018","journal-title":"Front Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1093\/infdis\/jix168","article-title":"Quantitative, phenotypical, and functional characterization of cellular immunity in children and adolescents with Down syndrome.","volume":"215","author":"Schoch","year":"2017","journal-title":"J Infect Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.1016\/j.vaccine.2013.09.070","article-title":"Functionality of the pneumococcal antibody response in Down syndrome subjects.","volume":"31","author":"Kusters","year":"2013","journal-title":"Vaccine."},{"key":"B18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/MD.0b013e3181fd8ec3","article-title":"clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.","volume":"89","author":"Picard","year":"2010","journal-title":"Medicine (Baltimore)."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1084\/jem.20070628","article-title":"Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity.","volume":"204","author":"Ku","year":"2007","journal-title":"J Exp Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1002\/ajmg.a.35706","article-title":"Changes in mortality and causes of death in the Swedish Down syndrome population.","author":"Englund","year":"2013","journal-title":"Am J Med Genet A."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1001\/jamaneurol.2018.2210","article-title":"Prevalence of aging, dementia, and multimorbidity in older adults with down syndrome.","volume":"75","author":"Bayen","year":"2018","journal-title":"JAMA Neurol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1001\/jamaneurol.2018.3616","article-title":"Association of dementia with mortality among adults with down syndrome older than 35 years.","volume":"76","author":"Hithersay","year":"2018","journal-title":"JAMA Neurol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0989-x","article-title":"Infection risk among adults with down syndrome: a two group series of 101 patients in a tertiary center.","volume":"14","author":"Guffroy","year":"2019","journal-title":"Orphanet J Rare Dis."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00840\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T01:18:47Z","timestamp":1588900727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00840\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,8]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2020.00840"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00840","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,8]]},"article-number":"840"}}